Xi’an Innov Biotechnology Co., Ltd. is excited to announce that we will be participating in the 31st Edition of the Dubai International Pharmaceutical & Technologies Conference and Exhibition (DUPHAT 2026), taking place from 24–26 March 2026 at the Dubai World Trade Center. This will be our first international exhibition of 2026, and we are really looking forward to joining this event in Dubai to connect with industry professionals and explore new opportunities in the fast-growing nutraceutical and wellness markets.
Dubai is a truly unique city, blending rich cultural heritage with modern innovation. Known for its incredible growth, world-class infrastructure, and dynamic business environment, it has become a global hub for trade, tourism, and technology. We’re excited to experience Dubai’s vibrant atmosphere and meet new partners in this exciting and diverse market. We believe that attending DUPHAT 2026 will provide valuable opportunities to expand our reach in the Middle East and Africa (MEA) region.
A Premier Platform in the MEA Region
DUPHAT is recognized as the largest pharmaceutical gathering in the Middle East & Africa, serving as a gateway for global companies seeking to strengthen their presence in the region. As an event that attracts over 32,000+ pharma professionals across the entire supply chain, DUPHAT plays a pivotal role in connecting C-level decision-makers, government health authorities, industry experts, and leading global pharmaceutical brands.
In parallel to the pharma sector’s growth, the nutraceutical market in the MEA region is rapidly expanding, driven by increasing health awareness and demand for innovative wellness solutions. This creates significant opportunities for companies to showcase cutting-edge supplement ingredients and delivery technologies. Events like the VITASHOW and DUPHAT provide a powerful platform for businesses to increase brand visibility and connect with key market players in nutraceuticals, pharmaceuticals, and health innovation.
Strong Momentum from 2025 Global Exhibitions
Xi’an Innov’s participation in DUPHAT follows a successful international exhibition year in 2025. The company showcased its ingredient innovations at:
-
Vitafoods Europe 2025 – Barcelona, Spain
-
PHARMED & HEALTHCARE VIETNAM 2025 – Ho Chi Minh City, Vietnam
-
Health Ingredients Japan 2025 – Tokyo, Japan
These exhibitions strengthened Xi’an Innov’s global partnerships, expanded its market reach, and reinforced its reputation as a leading supplier of advanced dietary supplement ingredients.
About Xi’an Innov Biotechnology
Established in 2008, Xi’an Innov Biotechnology specializes in high-quality dietary supplement ingredients, including plant extracts, nutritional raw materials, and advanced functional ingredient technologies. Over 17 years of development, the company’s facilities have achieved ISO 9001, ISO 22000, FDA, and GMP certifications, ensuring stringent quality control and international compliance.
In 2017, the company initiated its breakthrough research into absorption-enhancing technologies, leading to two major innovations:
-
Liposomal Encapsulation Technology
-
Sustained-Release Pellet Technology
These advanced delivery systems can increase ingredient absorption and bioavailability by several times, meeting the modern consumer demand for more effective supplements. As Xi’an Innov emphasizes, “Absorption rate is the ultimate pursuit of supplements.”
The company encourages brands and formulators worldwide to upgrade their existing ingredients into liposomal or pellet forms to gain new market advantages and create next-generation product offerings.
Looking Ahead to DUPHAT 2026
“DUPHAT stands as a global hub for pharmaceutical and nutraceutical innovation,” said the Xi'an Innov Biotechnology team. “We are excited to meet with distributors, raw material buyers, and industry leaders from across the MEA region. Our goal is to support partners in developing advanced, science-driven health solutions with superior absorption.”
Xi'an Innov Biotechnology welcomes all attendees to visit its booth at DUPHAT 2026, explore its portfolio of high-absorption supplement technologies, and discuss opportunities for customized formulation solutions.
